Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing
Status:
Recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
This Master Protocol for Avelumab Continuation Sub-Studies is to provide continued treatment
access, safety follow-up, and when applicable, overall survival follow-up for eligible
participants who continue to derive a benefit from study intervention in the Pfizer-sponsored
Avelumab parent studies.